Takeda-backed Ascentage Pharma aims to raise $126 million in US IPO
Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.
Montreal News40m
Venture Global, Inc. Announces Pricing of its Initial Public Offering
Venture Global, Inc. Announces Pricing of its Initial Public Offering Investor Contact Michael Pasquarello [email protected] Media Contact Shaylyn Hynes [email protected] ...
Venture Global LNG Raises $1.75 Billion After Pricing US IPO
(Reuters) -Venture Global LNG has raised $1.75 billion after pricing its U.S. initial public offering within range, the ...
Ascentage Pharma ADSs to Begin Trading on Nasdaq
Ascentage Pharma Group said its American depositary shares were slated to begin trading on the Nasdaq Global Market on Friday, with its initial public offering priced at $17.25 per ADS.